Not available
Quote | Sage Therapeutics Inc. (NASDAQ:SAGE)
Last: | $13.035 |
---|---|
Change Percent: | 2.63% |
Open: | $12.24 |
Close: | $13.035 |
High: | $13.5 |
Low: | $12.2 |
Volume: | 1,757,631 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Sage Therapeutics Inc. (NASDAQ:SAGE)
2024-04-18 16:56:16 ET Gainers: Travere Therapeutics ( TVTX ) +6% . Sabre Corporation ( SABR ) +5% . Nextracker ( NXT ) +3% . Cipher Mining ( CIFR ) +3% . BioCryst Pharmaceuticals ( BCRX ) +3% . Losers: Avidit...
2024-04-18 08:00:00 ET Summary Sage Therapeutics' investigational drug for Parkinson's disease, dalzanemdor, failed in a Phase 2 trial, leading to a 20% drop in the stock. Despite FDA approvals for PPD treatments, Sage's revenue remains low, impacting financial stability and marke...
Message Board Posts | Sage Therapeutics Inc. (NASDAQ:SAGE)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $SAGE News Article - "Buzz on the Street" Show: Sage Potash Corp. (TSX-V: SAGE) Expansi | whytestocks | investorshangout | 04/11/2023 8:35:50 PM |
whytestocks: $SAGE News Article - Breaking News: SAGE POTASH CORP. ANNOUNCES EXPANSION OF LAND PACKA | whytestocks | investorshangout | 04/11/2023 5:25:51 PM |
whytestocks: $SAGE News Article - Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Dr | whytestocks | investorshangout | 02/06/2023 5:05:46 PM |
whytestocks: $SAGE News Article - Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Dr | whytestocks | investorshangout | 02/06/2023 4:20:45 PM |
whytestocks: $SAGE News Article - Sage Therapeutics Announces Third Quarter 2022 Financial Results a | whytestocks | investorshangout | 11/08/2022 7:40:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Sage Therapeutics Inc. Company Name:
SAGE Stock Symbol:
NASDAQ Market:
Sage Therapeutics Inc. Website:
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded up 0.04% to...
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. Travelers repo...
U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.32% to 37,6...